Sichuan Kelun Pharmaceutical Co Ltd Financial Flexibility Index
Sichuan Kelun Pharmaceutical Co Ltd financial flexibility index. Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥930.89 Million (operating CF CN¥537.31 Million minus capex CN¥393.58 Million) represents 0% of total liabilities (CN¥11.48 Billion). Explore 002422 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Financial flexibility index of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Sichuan Kelun Pharmaceutical Co Ltd across 19 annual periods. Check total reinvestment intensity of Sichuan Kelun Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Sichuan Kelun Pharmaceutical Co Ltd Financial Flexibility Index by Year (2007–2025)
Sichuan Kelun Pharmaceutical Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Sichuan Kelun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002422 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.40x | CN¥4.26 Billion | CN¥2.64 Billion | CN¥10.54 Billion | ▼ -30.7% |
| 2024 | 0.58x | CN¥6.17 Billion | CN¥4.49 Billion | CN¥10.58 Billion | ▲ +10.3% |
| 2023 | 0.53x | CN¥7.11 Billion | CN¥5.34 Billion | CN¥13.44 Billion | ▲ +127.8% |
| 2022 | 0.23x | CN¥4.02 Billion | CN¥3.13 Billion | CN¥17.33 Billion | ▲ +5.3% |
| 2021 | 0.22x | CN¥3.84 Billion | CN¥2.85 Billion | CN¥17.41 Billion | ▲ +15.0% |
| 2020 | 0.19x | CN¥3.45 Billion | CN¥2.22 Billion | CN¥18.01 Billion | ▼ -5.1% |
| 2019 | 0.20x | CN¥3.55 Billion | CN¥2.22 Billion | CN¥17.58 Billion | ▼ -22.7% |
| 2018 | 0.26x | CN¥4.28 Billion | CN¥2.95 Billion | CN¥16.40 Billion | ▲ +56.0% |
| 2017 | 0.17x | CN¥2.68 Billion | CN¥1.20 Billion | CN¥16.01 Billion | ▼ -35.4% |
| 2016 | 0.26x | CN¥3.09 Billion | CN¥1.73 Billion | CN¥11.94 Billion | ▼ -3.9% |
| 2015 | 0.27x | CN¥3.08 Billion | CN¥1.24 Billion | CN¥11.42 Billion | ▼ -30.6% |
| 2014 | 0.39x | CN¥3.98 Billion | CN¥1.22 Billion | CN¥10.23 Billion | ▼ -7.0% |
| 2013 | 0.42x | CN¥3.31 Billion | CN¥1.05 Billion | CN¥7.92 Billion | ▼ -22.9% |
| 2012 | 0.54x | CN¥3.18 Billion | CN¥402.77 Million | CN¥5.87 Billion | ▼ -41.6% |
| 2011 | 0.93x | CN¥2.35 Billion | CN¥342.93 Million | CN¥2.53 Billion | ▲ +105.9% |
| 2010 | 0.45x | CN¥796.51 Million | CN¥149.29 Million | CN¥1.77 Billion | ▲ +50.0% |
| 2009 | 0.30x | CN¥525.98 Million | CN¥250.69 Million | CN¥1.75 Billion | ▼ -1.8% |
| 2008 | 0.31x | CN¥447.66 Million | CN¥221.08 Million | CN¥1.47 Billion | ▼ -2.6% |
| 2007 | 0.31x | CN¥343.47 Million | CN¥168.42 Million | CN¥1.10 Billion | — |